MBOT biotech catalysts & pipeline

MICROBOT MEDICAL INC · Data as of 2026-09-08

Upcoming catalysts

LIBERTY Endovascular Robotic System — Regulatory decision

Late 2026

The Company continues to pursue CE Mark certification and is working toward completion by the end of 2026, in preparation for the next phase of commercial expansion into the EU market.

Source filing

LIBERTY Endovascular Robotic System — Regulatory decision

Mar 2027

Internationally, we continue to establish a global infrastructure and implement our commercial readiness plans in Europe in anticipation of obtaining a CE Mark.

Source filing

Explore the free biotech catalyst calendar